title: Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women.
abstract: BACKGROUND
  Cohort studies suggest an association between variation in the estrogen receptor-alpha gene (ESR1) and cardiovascular disease (CVD), but data are lacking for the effect of variation in the estrogen receptor-beta gene (ESR2).
  
  
  METHODS
  Three polymorphisms of the ESR2 gene, and their associated haplotypes, were evaluated in 296 white women from the Women's Health Study and 566 white men from the Physicians' Health Study who developed CVD [myocardial infarction (MI) or ischemic stroke], each matched 1:1 to a member of the cohort study who remained free from CVD. Blood samples and cardiovascular risk information were collected at baseline.
  
  
  RESULTS
  Women, but not men, who developed CVD or MI, but not ischemic stroke, were more likely to have the rs1271572 polymorphism variant T allele (P = 0.05 and 0.02) and less likely to have the rs1256049 polymorphism variant A allele (P = 0.003 and 0.004). No associations were observed for rs4986938. In conditional logistic multivariate regression, the rs1271572 variant was associated with increased odds of CVD [odds ratio (OR) = 1.49, 95% CI: 1.10-2.01] and MI (OR = 1.46, 95% CI: 0.96-2.23), whereas the rs1256049 variant was associated with decreased odds of CVD (OR = 0.37, 95% CI: 0.17-0.79) and MI (OR = 0.25, 95% CI: 0.09-0.73) in women. A common haplotype that included the rs1271572 variant was associated with a 7-fold increased risk of MI in women.
  
  
  CONCLUSIONS
  Two tightly linked polymorphisms of ESR2 were associated with risk of CVD, particularly MI, in women but not men. Additional studies of ESR2 genetic variation and risk of CVD are warranted.
authors: Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. krexrode@partners.org
authors: Kathryn M
authors: KM
authors: Rexrode
authors: Paul M
authors: PM
authors: Ridker
authors: Hillary H
authors: HH
authors: Hegener
authors: Julie E
authors: JE
authors: Buring
authors: Joann E
authors: JE
authors: Manson
authors: Robert Y L
authors: RY
authors: Zee
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002545:Brain Ischemia / Q000150:complications; D002318:Cardiovascular Diseases / Q000209:etiology / Q000235:genetics*; D016022:Case-Control Studies; D015331:Cohort Studies; D047629:Estrogen Receptor beta / Q000235:genetics*; D005260:Female; D006239:Haplotypes; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000235:genetics; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D012306:Risk; D012737:Sex Factors; D020521:Stroke / Q000209:etiology / Q000235:genetics; D044465:White People
chemical_list: D047629:Estrogen Receptor beta
references: Eur J Hum Genet. 2005 Sep;13(9):1000-6
references: 15944651
references: Arch Med Res. 2005 Sep-Oct;36(5):511-7
references: 16099331
references: Circulation. 2005 Oct 4;112(14):2138-42
references: 16203927
references: Am J Hypertens. 2005 Nov;18(11):1388-95
references: 16280269
references: Circ Res. 2006 Mar 17;98(5):590-2
references: 16484614
references: Braz J Med Biol Res. 2006 Apr;39(4):447-54
references: 16612467
references: Hypertension. 2006 Jun;47(6):1019-26
references: 16651458
references: J Clin Endocrinol Metab. 2006 Jul;91(7):2713-20
references: 16608893
references: Am J Med. 2006 Sep;119(9 Suppl 1):S69-78
references: 16949391
references: Am J Med. 2006 Sep;119(9 Suppl 1):S61-8
references: 16949390
references: J Womens Health Gend Based Med. 2000 Jan-Feb;9(1):19-27
references: 10718501
references: Circulation. 2000 Apr 18;101(15):1792-8
references: 10769279
references: J Hum Genet. 2000;45(6):327-30
references: 11185739
references: Am J Hum Genet. 2001 Apr;68(4):978-89
references: 11254454
references: Metabolism. 2001 Dec;50(12):1447-51
references: 11735091
references: Science. 2002 Jan 18;295(5554):505-8
references: 11799247
references: J Mol Med (Berl). 2002 Mar;80(3):176-80
references: 11894143
references: Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):817-23
references: 12006396
references: Vascul Pharmacol. 2002 Feb;38(2):99-108
references: 12379956
references: Hum Mol Genet. 2003 Feb 1;12(3):205-16
references: 12554675
references: Am J Hum Genet. 2003 Nov;73(5):1162-9
references: 14574645
references: JAMA. 2003 Nov 5;290(17):2263-70
references: 14600184
references: JAMA. 2004 Jun 23;291(24):2969-77
references: 15213208
references: N Engl J Med. 1989 Jul 20;321(3):129-35
references: 2664509
references: Curr Opin Cardiol. 1994 Sep;9(5):619-26
references: 7987043
references: Genomics. 1995 Sep 20;29(2):311-22
references: 8666377
references: Circ Res. 1998 Jul 27;83(2):224-9
references: 9686763
references: J Clin Endocrinol Metab. 1998 Dec;83(12):4524-7
references: 9851804
references: Pharmacogenomics J. 2005;5(1):30-4
references: 15381922
references: J Clin Endocrinol Metab. 2005 Feb;90(2):1041-6
references: 15536156
references: N Engl J Med. 2005 Mar 31;352(13):1293-304
references: 15753114
references: Stroke. 2005 Oct;36(10):2281-2
references: 16179580